News

Purple Biotech to Showcase Innovations at Investment Conference

Purple Biotech to Showcase Innovations at Investment Conference

Purple Biotech to Present Innovations at Investment Conference

Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is making significant strides in the biotechnology industry as a clinical-stage company focused on developing innovative therapies to combat tumor immune evasion and drug resistance. The executive team is thrilled to share that they will be participating in the esteemed H.C. Wainwright 26th Annual Global Investment Conference. During this event, they will host a virtual Fireside Chat and hold one-on-one meetings with institutional investors.

Conference Details

The conference is set to take place from September 9-11. Purple Biotech's virtual Fireside Chat will be available for on-demand viewing starting at 7:00 AM ET on September 9. Those interested can access the presentation in the Investor section of Purple Biotech’s website, where it will remain available for 30 days, providing ample opportunity to gain insights into the company's innovative strategies.

Investor Engagement Opportunities

For investors eager to participate in the Fireside Chat, a simple registration link is provided to secure their spot in this informative session. Furthermore, CEO Gil Efron will be available for personalized one-on-one meetings with investors at the Lotte New York Palace Hotel, showcasing Purple Biotech's commitment to open communication and collaboration with its stakeholders.

Exploring Purple Biotech’s Innovative Pipeline

Purple Biotech is at the forefront of oncology, boasting a robust pipeline that includes promising candidates such as CM24, NT219, and IM1240. Each of these candidates is designed to tackle significant challenges in cancer treatment.

CM24: Advancing Cancer Treatment

CM24 is a humanized monoclonal antibody that specifically targets CEACAM1, a protein crucial for tumor immune evasion and survival. Its innovative design aims to disrupt various pathways that tumors utilize to thrive. Currently, CM24 is undergoing a Phase 2 study for the treatment of pancreatic ductal adenocarcinoma (PDAC) in combination with anti-PD-1 checkpoint inhibitors. This effort includes a key partnership with Bristol Myers Squibb, highlighting Purple Biotech’s commitment to collaborative advancements in cancer care.

Progress with NT219 and IM1240

Another exciting development is NT219, a novel small molecule that inhibits both IRS1/2 and STAT3. After successful Phase 1 trials, it is moving forward for further investigation, particularly regarding its anti-tumor properties in recurrent and metastatic head and neck cancers. Additionally, IM1240 represents Purple Biotech’s cutting-edge work with its tri-specific antibody that targets the antigen 5T4, which is closely associated with various solid tumors.

The Company’s Vision and Future Directions

Purple Biotech is committed to harnessing the immune system's potential to more effectively combat cancers. Their innovative development platform focuses on creating therapies that activate both innate and adaptive immune responses, a comprehensive approach that could transform patient outcomes.

Headquartered in Rehovot, Israel, Purple Biotech is dedicated to pushing the limits of what is achievable in oncology. For more information about their ongoing projects and developmental progress, interested parties can visit their official website.

Frequently Asked Questions

What is the focus of Purple Biotech?

Purple Biotech is focused on developing first-in-class therapies aimed at overcoming tumor immune evasion and drug resistance.

When is the H.C. Wainwright Investment Conference?

The conference is scheduled for September 9-11, with a virtual Fireside Chat available for on-demand viewing starting on September 9 at 7:00 AM ET.

What are the main products under development by Purple Biotech?

The key products in development include CM24, NT219, and IM1240, which focus on innovative strategies for cancer treatment.

Where is Purple Biotech located?

The company is headquartered in Rehovot, Israel.

How can investors learn more about Purple Biotech's developments?

Investors can visit the company's official website to find information about ongoing projects and clinical advancements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 6

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 2

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 6

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
BusyBee AI Revolutionizes Classroom Feedback Efficiency

Updated Category News Views 7

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Continue Reading

Top 5 Most Recently Viewed Articles

First Industrial Realty Trust Excels in Q2 2025 Performance

Updated Category News Views 170

Strong Financial Results for First Industrial Realty Trust First Industrial Realty Trust, Inc. (NYSE: FR) announced notable financial results for its second quarter of 2025. This leading owner and operator of logistics real estate illustrated a remarkable cash same-store net operating income (NOI) growth of 8.7%, showcasing its strong market position and operational...

Continue Reading
Range Resources Announces New Quarterly Dividend

Updated Category News Views 84

Range Resources Announces New Quarterly Dividend Range Resources Corporation (NYSE: RRC) has shared some exciting news about its dividend distribution. The company's Board of Directors has officially declared a cash dividend of $0.08 per share, which is set to be distributed in the third quarter. This decision highlights Range's dedication to delivering value to its loyal...

Continue Reading
Highlights of Ringkjøbing Landbobank's Recent Buyback Program

Updated Category News Views 157

Completion of the Share Buyback Program The share buyback program initiated by Ringkjøbing Landbobank has successfully completed its target of DKK 500 million. This initiative demonstrated the bank’s commitment to enhancing shareholder value. The buybacks took place between January 28 and May 28. Details of the Transactions During the reporting period, several...

Continue Reading
Monte Rosa Therapeutics Updates on MRT-2359 Study Progress

Updated Category News Views 175

Monte Rosa Therapeutics Announces Progress in MRT-2359 Study Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a pioneering clinical-stage biotechnology company, has shared exciting updates regarding its ongoing Phase 1/2 study of MRT-2359. This innovative treatment targets MYC-driven solid tumors and has shown promising results in patient safety and drug efficacy. Key Study...

Continue Reading
Pentagon Budget Sparks AI Innovations in Defense Sector

Updated Category News Views 103

Defense Sector Transforms with AI Technologies The recent authorization of a significant $900.6 billion Pentagon budget marks the beginning of a dynamic transformation in the defense industry. This substantial financial allocation urges the need for innovation in electronic warfare and advanced sensing technologies as the complexity of modern threats increases. Experts...

Continue Reading